期刊文献+

含有异噁唑的S-三唑[3,4-b]-1,3,4-噻二嗪、咪唑[2,1-b]-1,3,4-噻二唑和咪唑[2,1-b]-1,3,4-噁二唑衍生物的合成 被引量:9

Synthesis of S-Triazolo-1,3,4-thiadiazine, Imidazolo- 1,3,4-thiadiazole and Imidazolo-1,3,4-oxadiazole Derivatives Containing Isoxazole
下载PDF
导出
摘要 Isoxazole derivatives were characterized by broad spectrum of biological activities, but the condensed heterocyclic compounds containing isoxazole were scarcely reported. In this paper, we studied the 1,3-dipolar cycloaddition of p-methoxybenzohydroxamoyl chloride with ethyl sodioacetoacetate to obtain a key intermediate 2. Through compound 2, fifteen novel S-triazolo-1,3,4-thiadiazines(5a-5e), imidazolo-1,3,4-thiadiazoles(9a-9e) and imidazolo-1,3,4-oxadiazoles(10a-10e) containing isoxazole, which have potentially useful biological activities, were synthesized. The structures of the products were confirmed by elemental analyses and spectral analysis. And the characteristic data of IR, 1H NMR and MS were explained reasonably. Isoxazole derivatives were characterized by broad spectrum of biological activities, but the condensed heterocyclic compounds containing isoxazole were scarcely reported. In this paper, we studied the 1,3-dipolar cycloaddition of p-methoxybenzohydroxamoyl chloride with ethyl sodioacetoacetate to obtain a key intermediate 2. Through compound 2, fifteen novel S-triazolo-1,3,4-thiadiazines(5a-5e), imidazolo-1,3,4-thiadiazoles(9a-9e) and imidazolo-1,3,4-oxadiazoles(10a-10e) containing isoxazole, which have potentially useful biological activities, were synthesized. The structures of the products were confirmed by elemental analyses and spectral analysis. And the characteristic data of IR, 1H NMR and MS were explained reasonably.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2004年第9期1673-1675,共3页 Chemical Journal of Chinese Universities
基金 国家自然科学基金 (批准号 :2 970 2 0 0 7 2 0 162 0 0 4)资助
关键词 异噁唑 均三唑并噻二嗪 咪唑[2 1-b]-1 3 4-噻二唑 咪唑[2 1-b]-1 3 4-噁二唑 Isoxazole S-Triazolo-1,3,4-thiadiazine Imidazolo-1,3,4-thiadiazole Imidazolo-1,3,4-oxadiazole
  • 相关文献

参考文献12

  • 1Adolphe-Pierre S. , Menager S. , Tombret F. et al.. IL Farmaco[J], 1998, 53:513-518 被引量:2
  • 2Dulin W. E. , George H. L. , George C. G.. Proc. Soc. Exptl. Biol. Med. [J], 1965, 118(2): 499-501 被引量:2
  • 3Stanislaw R. , Zdzislaw M. , Zbigniew W. et al.. Eur. J. Med. Chen. [J], 1998, 33:831-836 被引量:2
  • 4Parasad A. R. , Ramalingam T. , Rao A. B. et al.. Eur. J. Med. Chem. [J], 1989, 24:199-205 被引量:2
  • 5JoshiM. N., BhagwatV. S., ParvateJ. A.. J. Indian Chem. Soc.[J], 1993, 70(7): 647-648 被引量:1
  • 6Tosten B. , Dicter S. , Horst W.. J. Heterocyclic Chem. [J], 1997, 34: 453-455 被引量:2
  • 7Nardii D. , Tajiana A. , Leouardi A. et al.. J. Med. Chem. [J], 1981, 24:727-731 被引量:1
  • 8DoyleFi P., HansonJ. C., LongA. A. W. et al.. J. Am. Chem. Soc.[J], 1963, 85:5845-5854 被引量:1
  • 9Xu P. F. , Yang X. P. , Wu S. Z. et al.. Indian J. Chem. [J], 1998, 37B(2): 127-129 被引量:1
  • 10Reid J. R. , Heindel N. D.. J. Heterocyclic Chem. [J], 1976, 13:925-927 被引量:1

二级参考文献2

共引文献12

同被引文献67

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部